Lineage Cell Therapeutics, Inc. (LCTX)

ASE – Real vaqt narxi. Valyuta: USD

1.11

-0.01 (-1.33%)

Bozor ochiq: Aug 12, 2026, 2:54 PM EDT

1.13

+0.01 (0.88%)

Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT

09.08.2026

Lineage Cell Therapeutics Q2 Earnings Call Highlights

Lineage Cell Therapeutics NYSEAMERICAN: LCTX outlined progress across its cell-therapy pipeline during its second-quarter 2026 earnings call, highlighting preclinical advances in corneal disease, Type 1 diabetes and hearing loss programs while Roche and Genentech continue surgical-delivery optimization work for its lead OpRegen program.

07.08.2026

Lineage Cell Therapeutics, Inc. (LCTX) Q2 2026 Earnings Call Transcript

06.08.2026

Lineage Cell (LCTX) Reports Q2 Loss, Lags Revenue Estimates

Lineage Cell (LCTX) came out with a quarterly loss of $0.03 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.01 per share a year ago.

06.08.2026

Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #LineageCellTherapeutics--Q2 2026 Earnings Release.

Videolar

No Data

There is no data to display

Press-relizlar

06.08.2026

Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #LineageCellTherapeutics--Q2 2026 Earnings Release.

Lineage Cell Therapeutics, Inc. (LCTX)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Lineage Cell Therapeutics, Inc. (LCTX)

Lineage Cell Therapeutics Q2 Earnings Call Highlights

Lineage Cell Therapeutics, Inc. (LCTX) Q2 2026 Earnings Call Transcript

Lineage Cell (LCTX) Reports Q2 Loss, Lags Revenue Estimates

Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Videolar

No Data

Press-relizlar

Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Lineage Cell Therapeutics Q2 Earnings Call Highlights

Lineage Cell Therapeutics, Inc. (LCTX) Q2 2026 Earnings Call Transcript

Lineage Cell (LCTX) Reports Q2 Loss, Lags Revenue Estimates

Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Videolar

No Data

Press-relizlar

Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Search stocks

Lineage Cell Therapeutics, Inc. (LCTX)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Lineage Cell Therapeutics, Inc. (LCTX)

Lineage Cell Therapeutics Q2 Earnings Call Highlights

Lineage Cell Therapeutics, Inc. (LCTX) Q2 2026 Earnings Call Transcript

Lineage Cell (LCTX) Reports Q2 Loss, Lags Revenue Estimates

Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Videolar

No Data

Press-relizlar

Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Lineage Cell Therapeutics Q2 Earnings Call Highlights

Lineage Cell Therapeutics, Inc. (LCTX) Q2 2026 Earnings Call Transcript

Lineage Cell (LCTX) Reports Q2 Loss, Lags Revenue Estimates

Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Videolar

No Data

Press-relizlar

Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update